Fig. 1

Tumor growth of human TNBC cell xenografts implanted in immunocompromised female NOD-SCID mice. A Characteristics of six human TNBC cell lines used in the study. IDC, invasive ductal carcinoma; B Tumor volume over time for each cell line 231, 468, BT549, Hs578T, BT20, and SUM159. C Tumor volume at the terminal endpoint. Data are shown as mean with SEM, n = 8–10 animals/group. Significance was determined using a one-way ANOVA with Tukey’s multiple comparison test comparing each cell line to every other cell line. Significance (p < 0.05) is denoted by a letter corresponding to each cell line tested, 231 (a), 468 (b), BT549 (c), BT20 (d), SUM159 (e), Hs578T (f)